SI-BONE, Inc. Files 8-K on Financials

Ticker: SIBN · Form: 8-K · Filed: 2025-05-05T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: SIBN

TL;DR

SI-BONE filed an 8-K on 5/5/25 with financial updates. Check it out.

AI Summary

On May 5, 2025, SI-BONE, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, providing an update on the company's performance. SI-BONE, Inc. is incorporated in Delaware and its fiscal year ends on December 31st.

Why It Matters

This 8-K filing provides investors with crucial, up-to-date information on SI-BONE, Inc.'s financial health and operational results, impacting investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine financial disclosure and does not appear to contain any immediate negative news or significant changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for SI-BONE, Inc.?

The primary purpose of this 8-K filing is to report on SI-BONE, Inc.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on May 5, 2025.

In which state is SI-BONE, Inc. incorporated?

SI-BONE, Inc. is incorporated in Delaware.

What is the SIC code for SI-BONE, Inc.?

The Standard Industrial Classification (SIC) code for SI-BONE, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is SI-BONE, Inc.'s fiscal year end?

SI-BONE, Inc.'s fiscal year ends on December 31st.

From the Filing

0001459839-25-000059.txt : 20250505 0001459839-25-000059.hdr.sgml : 20250505 20250505161245 ACCESSION NUMBER: 0001459839-25-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250505 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SI-BONE, Inc. CENTRAL INDEX KEY: 0001459839 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 262216351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38701 FILM NUMBER: 25913077 BUSINESS ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 4082070700 MAIL ADDRESS: STREET 1: 471 EL CAMINO REAL, SUITE 101 CITY: SANTA CLARA STATE: CA ZIP: 95050 FORMER COMPANY: FORMER CONFORMED NAME: SI-Bone Inc. DATE OF NAME CHANGE: 20090326 8-K 1 sibn-20250505.htm 8-K sibn-20250505 0001459839 false 0001459839 2025-05-05 2025-05-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM  8-K ____________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2025 ____________________________________________________________________________ SI-BONE, INC. (Exact name of registrant as specified in its charter) ____________________________________________________________________________ Delaware   001-38701   26-2216351 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (I.R.S. Employer Identification No.) 471 El Camino Real Suite 101 Santa Clara , CA 95050 (Address of principal executive offices) (Zip Code) ( 408 ) 207-0700 (Registrant’s telephone number, include area code) N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share SIBN The Nasdaq Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company    ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition. On May 5, 2025, SI-BONE, Inc. (the "Company") issued a press release (the “Press Release”) announcing results for the quarter ended March 31, 2025. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference

View on Read The Filing